000 | 01526 a2200445 4500 | ||
---|---|---|---|
005 | 20250517165259.0 | ||
264 | 0 | _c20170922 | |
008 | 201709s 0 0 eng d | ||
022 | _a1744-764X | ||
024 | 7 |
_a10.1080/14740338.2017.1354986 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJiang, Nan | |
245 | 0 | 0 |
_aRisk of gastrointestinal complications in breast cancer patients treated with neratinib: a meta-analysis. _h[electronic resource] |
260 |
_bExpert opinion on drug safety _cOct 2017 |
||
300 |
_a1111-1119 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Meta-Analysis | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aDiarrhea _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNausea _xchemically induced |
650 | 0 | 4 |
_aQuinolines _xadministration & dosage |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aVomiting _xchemically induced |
700 | 1 | _aSong, Xiang-Wei | |
700 | 1 | _aLin, Jing-Jing | |
700 | 1 | _aWang, Zhan-Yu | |
700 | 1 | _aZhang, Bei-Ning | |
700 | 1 | _aLi, Ao | |
700 | 1 | _aYan, Ru-Yi | |
700 | 1 | _aYan, Hong-Feng | |
700 | 1 | _aFu, Xiao-Yan | |
700 | 1 | _aZhou, Jin-Lian | |
700 | 1 | _aLi, Cheng-Lin | |
700 | 1 | _aCui, Yan | |
773 | 0 |
_tExpert opinion on drug safety _gvol. 16 _gno. 10 _gp. 1111-1119 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/14740338.2017.1354986 _zAvailable from publisher's website |
999 |
_c27424717 _d27424717 |